Instituut voor Neuropathische Pijn

Home

Cancer and neuropathy

Lema, Foley and Hausheer from the Roswell Park Cancer Institute, Buffalo, New York, USA analysed some relevant issue related to the epidemiology and symtoms, as well as the neuropathic pain in patients with cancer.

They state that neuropathic pain is widely recognized as a common consequence of cancer and results as side effects of various oncology drugs.

These side effects impacts negatively the quality of life, as well as thye patient outcomes because of resulting treatment delays, dose reductions, and discontinuations.

The authors estimated that the cost of the problem in the U.S. alone is approximately $2.3 billion.

^[1]

June 2010, Jan M. Keppel Hesselink, MD, PhD

Referenties

[1]: Lema MJ, Foley KM, Hausheer FH. | Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. | Oncologist. | 2010;15 Suppl 2:3-8.